Literature DB >> 32419915

How to manage adult coeliac disease: perspective from the NHS England Rare Diseases Collaborative Network for Non-Responsive and Refractory Coeliac Disease.

Elisabeth Megan Rose Baggus1, Marios Hadjivassiliou1, Simon Cross1, Hugo Penny1, Heidi Urwin2, Sarah Watson3, Jeremy Mark Woodward4, David S Sanders5.   

Abstract

Adult coeliac disease (CD) affects approximately 1% of the population. Most patients diagnosed will respond to a gluten-free diet; however, up to 30% may have persisting symptoms. Such patients may have ongoing issues associated with adherence, non-responsive CD or refractory CD. This article provides a clinical overview of how to manage this group of patients with persisting symptoms, including an investigational algorithm and details of how to contact the National Health Service England Rare Diseases Collaborative Network for Non-Responsive and Refractory Coeliac Disease. We hope this will be a valuable source of contemporary information for all UK gastroenterologists and internationally. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  coeliac disease; small bowel; small bowel disease; small intestine

Year:  2019        PMID: 32419915      PMCID: PMC7223293          DOI: 10.1136/flgastro-2019-101191

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  72 in total

1.  Evaluation of Cladribine treatment in refractory celiac disease type II.

Authors:  Greetje J Tack; Wieke H M Verbeek; Abdul Al-Toma; Dirk J Kuik; Marco W J Schreurs; Otto Visser; Chris J J Mulder
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

2.  Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells.

Authors:  Abdulbaqi Al-toma; Otto J Visser; Hyacintha M van Roessel; B Mary E von Blomberg; Wieke H M Verbeek; Petra E T Scholten; Gert J Ossenkoppele; Peter C Huijgens; Chris J J Mulder
Journal:  Blood       Date:  2006-10-26       Impact factor: 22.113

3.  Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet.

Authors:  Alberto Rubio-Tapia; Mussarat W Rahim; Jacalyn A See; Brian D Lahr; Tsung-Teh Wu; Joseph A Murray
Journal:  Am J Gastroenterol       Date:  2010-02-09       Impact factor: 10.864

4.  Treatment of life-threatening type I refractory coeliac disease with long-term infliximab.

Authors:  G Costantino; A della Torre; M A Lo Presti; R Caruso; E Mazzon; W Fries
Journal:  Dig Liver Dis       Date:  2007-03-26       Impact factor: 4.088

5.  Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes.

Authors:  Seiji Yokoyama; Nobumasa Watanabe; Noriko Sato; Pin-Yu Perera; Lyvouch Filkoski; Toshiyuki Tanaka; Masayuki Miyasaka; Thomas A Waldmann; Takachika Hiroi; Liyanage P Perera
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-01       Impact factor: 11.205

6.  Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery.

Authors:  Peter J Wahab; Jos W R Meijer; Chris J J Mulder
Journal:  Am J Clin Pathol       Date:  2002-09       Impact factor: 2.493

7.  Azathioprine and prednisone combination therapy in refractory coeliac disease.

Authors:  M S Goerres; J W R Meijer; P J Wahab; J A M Kerckhaert; P J T A Groenen; J H J M Van Krieken; C J J Mulder
Journal:  Aliment Pharmacol Ther       Date:  2003-09-01       Impact factor: 8.171

8.  Monitoring of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces.

Authors:  Isabel Comino; Ana Real; Santiago Vivas; Miguel Ángel Síglez; Alberto Caminero; Esther Nistal; Javier Casqueiro; Alfonso Rodríguez-Herrera; Angel Cebolla; Carolina Sousa
Journal:  Am J Clin Nutr       Date:  2012-01-18       Impact factor: 7.045

9.  Outcome of Referrals for Non-Responsive Celiac Disease in a Tertiary Center: Low Incidence of Refractory Celiac Disease in the Netherlands.

Authors:  R L J van Wanrooij; G Bouma; H J Bontkes; A Neefjes-Borst; N C van Grieken; B M E von Blomberg; C J J Mulder
Journal:  Clin Transl Gastroenterol       Date:  2017-01-26       Impact factor: 4.488

10.  Recognising and Managing Refractory Coeliac Disease: A Tertiary Centre Experience.

Authors:  Ikram Nasr; Iman Nasr; Carl Beyers; Fuju Chang; Suzanne Donnelly; Paul J Ciclitira
Journal:  Nutrients       Date:  2015-12-01       Impact factor: 5.717

View more
  3 in total

Review 1.  Current and emerging therapies for coeliac disease.

Authors:  Laura Kivelä; Alberto Caminero; Daniel A Leffler; Maria Ines Pinto-Sanchez; Jason A Tye-Din; Katri Lindfors
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-11-20       Impact factor: 46.802

2.  Adult celiac disease with persistent IBS-type symptoms: a pilot study of an adjuvant FODMAP diet.

Authors:  Nick Trott; Anupam Rej; Sarah H Coleman; David S Sanders
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021

Review 3.  Celiac Disease and Possible Dietary Interventions: From Enzymes and Probiotics to Postbiotics and Viruses.

Authors:  Sandip K Wagh; Karen M Lammers; Manohar V Padul; Alfonso Rodriguez-Herrera; Veronica I Dodero
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.